The imminent publication of eagerly anticipated new international guidelines promises to transform the complex area of lung cancer staging.
In two separate education exhibits at RSNA 2008, presenters from the U.S. and France urge all radiologists to become familiar with the seventh edition of the tumor, node, metastasis classification for lung cancer. The International Association for the Study of Lung Cancer is due to publish its recommendations in early 2009.
The original TNM staging of lung cancer proposed in 1973 was based on 2155 cases from the database of Dr. Clifton Mountain from M.D. Anderson Cancer Center in Houston. By 1997, this database had grown to 5319 cases, and it long remained the primary basis for the classification of malignant tumors. But then the IASLC got involved, eventually resulting in a huge new database of more than 81,000 cases obtained between 1990 and 2000.
"Given the important role radiologists play in the staging of lung cancer, an understanding of the new classification system will be necessary for relevant imaging analysis of lung cancer patients," said Dr. Constantin A. Raptis, a radiologist from Washington University.
The authors of the seventh edition have made substantial changes for T and M staging, but they have left N staging unchanged. For T staging, they have introduced new size stratifications, as well as reassignment of several invasion criteria. For M staging, they have formulated a subclassification for M1a and M1b metastases.
The new recommendations look set to be accepted as a guide for estimating patient prognosis. They will form the basis for treatment decisions in practice, according to Dr. Antoine Micheau, a radiologist from the department of thoracic and cardiovascular radiology at the Arnaud de Villeneuve University Hospital in Montpellier.
Extensive corrections have been made to remove many deficiencies of the old staging system, he said. The sixth edition from 2002 contains many controversial aspects. For instance, a satellite tumor nodule in the primary lobe was defined as T4, but some experts suggested that it might behave more favourably than in patients with another subgroup of T4. As a result, distinguishing the prognosis of patients with stage 3a and 3b was sometimes unclear.
"The proposed changes will improve the alignment of TNM stage with prognosis and treatment," Micheau said.
|
DiagnosticImaging.com. Lung cancer staging undergoes major overhaul
By Philip Ward |
November 30, 2008
RSNA 2008 November 30
Following simple steps can minimize risk of being sued
November 30, 2008 Legal and regulatory issues have a growing impact on how radiologists perform procedures and studies, report results, and structure their practices. Implementing a simple checklist may help to reduce the prospect of being sued for malpractice. Standardized chemoembolization protocol boosts liver cancer patient survival
November 30, 2008 Results from the largest and longest trial of its kind suggest that patients with intermediate and advanced hepatocellular carcinomas who undergo systematic treatment with three chemotherapeutic agents and arterial embolization plus imaging follow-up have better survival rates than those who undergo nonstandardized chemoembolization regimes. Lung cancer staging undergoes major overhaul
November 30, 2008 The imminent publication of eagerly anticipated new international guidelines promises to transform the complex area of lung cancer staging. PET/CT in prostate cancer influences staging, treatment strategy
November 30, 2008 Prostate-specific antigen measurements are considered a useful organ-specific marker, but they are not necessarily an adequate tumor marker. PET/CT in combination with PSA levels can play a significant role in detecting and staging prostate cancer, according to two presentations Sunday at RSNA 2008. Diffusion tensor imaging measurements may help diagnosis of spinal cord trauma
November 30, 2008 A new technique may help characterize diffusion anisotropy in the spinal cord in a clinical setting. Researchers have determined that using 3D single-shot diffusion-weighted stimulated echo-planar imaging in the cervical spinal cord results in higher resolution and less distortion than 2D single-shot diffusion-weighted echo-planar imaging. Learning never stops in globalized world of healthcare
November 30, 2008 Lifelong learning in an era of globalized healthcare science and practice is essential, according to Sunday’s opening session of RSNA 2008, which also stressed the need for standardization in training and certification. SuperSonic builds on breast elastrography
November 30, 2008 Elastrography forms the cornerstone of an ultrasound system unveiled by first-time RSNA exhibitor SuperSonic Imagine. The Aixplorer system is dedicated to breast imaging. It differentiates healthy from cancerous tissues by quantifying differences in the elasticity of the tissues. SuperSonic’s ShearWave Elastography technique produces consistent results regardless of the operator’s skill, according to the company. Philips ultrasound upgrade targets breast imaging
November 30, 2008 Enhancements in breast imaging mark the latest ultrasound upgrade from Philips Healthcare. Tissue aberration correction technology and algorithms built into the Vision 2009 upgrade for its iU22 radiological flagship are part of an integrated effort to better define tissue in fatty breasts, according to the company. An enabling technology is the Philips PureWave transducer and its coded beamformer, which have been present on earlier technologies. Naviscan readies PET biopsy
November 30, 2008 PET niche developer Naviscan arrived at the RSNA meeting with permission from the FDA to launch its Stereo Navigator, a biopsy guidance feature for its breast-specific PET scanner. Stereo Navigator can localize lesions as small as 2 mm. It uses a stereotactic frame fixed between the scanner’s paddles to guide a biopsy needle into the breast. Localization is verified using a PET-visible line source inserted into the needle track. This allows the user to confirm trajectory and position. The PET-guidance accessory is compatible with biopsy devices from Ethicon Endo-Surgery, Hologic, and SenoRx. Invivo unveils next-generation MR-compatible monitor
November 30, 2008 Invivo introduced at RSNA 2008 its sixth-generation vital signs monitor for use in MR suites. The Precess Patient Management Configuration uses the industry’s first wireless ECG and wireless SpO2 patient vital signs. Built on the company’s flagship Precess 3160 platform, the new system features a flexible mounting that allows attachment to anesthesia machines, a wall, or an MRI table. |
|
